IPO

China Feihe’s $1.1b IPO goes for prudent pricing strategy

Listing against the backdrop of social unrest in Hong Kong, China’s largest infant milk formula maker stays cautious with pricing and leaves something on the table for prospective investors.

Infant milk formula manufacturer China Feihe is poised to give the Hong Kong stock exchange another boost following the revival of two billion-dollar flotations earlier this year, assuming it completes an initial public offering of up to HK$8.9 billion ($1.1 billion) next week.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media